Dostinex

In the US, Dostinex (cabergoline systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, prolactin inhibitors and is used to treat Hyperprolactinemia.

US matches:

• Dostinex

UK matches:

• Dostinex Tablets (SPC)

Ingredient matches for Dostinex

Cabergoline

Cabergoline is reported as an ingredient of Dostinex in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Canada


• Chile


• Colombia


• Costa Rica


• Czech Republic


• Ecuador


• El Salvador


• Finland


• France


• Georgia


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Iceland


• Ireland


• Israel


• Italy


• Latvia


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Poland


• Portugal


• Romania


• Russian Federation


• Singapore


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.